David A. Siegel Venus Concept Inc. Transaction History

Two Sigma Advisers, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.16 - $6.5 $889 - $36,133	-5,559 Reduced 28.42%	14,000 $4,000
Q3 2022 Nov 14, 2022	SELL	$0.31 - $7.41 $33,697 - $805,467	-108,700 Reduced 84.75%	19,559 $9,000
Q2 2022 Aug 15, 2022	SELL	$0.45 - $1.57 $12,420 - $43,332	-27,600 Reduced 17.71%	128,259 $59,000
Q1 2022 May 16, 2022	SELL	$1.29 - $1.85 $181,761 - $260,665	-140,900 Reduced 47.48%	155,859 $223,000
Q4 2021 Feb 14, 2022	SELL	$1.19 - $2.42 $119,952 - $243,936	-100,800 Reduced 25.35%	296,759 $504,000
Q3 2021 Nov 15, 2021	BUY	$1.79 - $3.27 $589,984 - $1.08 Million	329,600 Added 485.0%	397,559 $998,000
Q2 2021 Aug 16, 2021	BUY	$1.72 - $3.19 $116,889 - $216,789	67,959 New	67,959 $211,000

Ticker VERO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 65,459,600
Market Cap $20.9M
Description
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device us...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.